Table 8 Application of LPHNPs in the treatment of brain tumors
Sr. No | Lipid component | Polymer component | Targeting moiety | Drug | In vitro | In vivo | Ref |
|---|---|---|---|---|---|---|---|
1 | Glyceryl mono stearate, Stearic acid | Chitosan | _ | Carbamazepine | _ | Wister rats | [286] |
2 | DSPE-PEG-2000, DPPC, cholesterol | PLGA | cRGD | CRISPR/Cas9 | T98G cells | NOD-SCID mice | [291] |
3 | Lecithin, Soybean phosphatidylcholine, | PLGA | Tocopherol | Rutin (Flavanoid) | _ | Swiss mice | [294] |